Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.4.4 (
adenosine deaminase
)
5,136
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The distribution of the phenotypes of the red cell enzymes
adenosine deaminase
, adenylate kinase, glutamate
pyruvate dehydrogenase
, 6-phosphogluconate dehydrogenase and phosphoglucomutase was studied in blood samples of 794 West Hungarian subjects and 955 subjects from Franconia in Bavaria. All enzymes were separated on cellulose acetate foil, SEP in starch gel. The method of separation has been described elsewhere. The phenotypes of all enzymes were found to be distributed according to the Hardy-Weinberg law. The calculated gene frequencies were in good agreement with data from the literature, according to the results of other investigations carried out in Germany and the central European region. No significant difference was found between the gene frequencies of these enzyme phenotypes in West Hungary and Franconia, although the PGM2 frequency level was higher in West Hungary than in Franconia.
...
PMID:[Comparative investigations on polymorphism of the red cell enzymes in Franconia and West Hungary (author's transl)]. 63 41
ACTH, isoprenaline, forskolin, and dibutyryl cyclic AMP prevented insulin from stimulating adipocyte
pyruvate dehydrogenase
in the presence of
adenosine deaminase
. Antagonism was reversed by N6-phenylisopropyladenosine as well as oxytocin. The stimulatory effects of insulin, adenosine and oxytocin on adipocyte
pyruvate dehydrogenase
appear to be through (a) mechanism(s) which is (are) similar or related.
...
PMID:Adenosine and oxytocin reverse antagonism of cyclic AMP elevating agents to insulin activation of adipocyte pyruvate dehydrogenase. 303 Aug 21
Adenosine and its analogue N6-phenylisopropyladenosine stimulated
pyruvate dehydrogenase
activity of isolated rat adipocytes. Maximal stimulation was obtained with concentrations between 50 and 100 mu M, with the effect decreasing at higher concentrations. The effects of insulin on this enzyme was modified by adenosine. The concentration of insulin (10 mu units/ml) that produced almost half-maximal stimulation, had little or no effect, when
adenosine deaminase
was present. Adenosine also enhanced the effect of suboptimal but not optimal concentrations of insulin. Thus, the mechanism of adenosine action on adipocyte
pyruvate dehydrogenase
could in some way be similar or related to that of insulin.
...
PMID:Effect of adenosine on insulin activation of rat adipocyte pyruvate dehydrogenase. 638 62
Exposure to phospholipase C increased the incorporation of [32P]Pi into phosphatidate, CMP-phosphatidate and phosphatidylinositol in rat adipose tissue and isolated adipocytes. A similar effect was observed in response to insulin and oxytocin. Theophylline, 3-isobutyl-1-methylxanthine and
adenosine deaminase
decreased [32P]Pi incorporation, and adenosine and N6-phenylisopropyladenosine reversed these effects. As with insulin, exposure of adipose tissue to phospholipase C stimulated oxidation of glucose, pyruvate and leucine and activated
pyruvate dehydrogenase
. Oxytocin and adenosine also mimicked the effects of insulin on leucine oxidation and
pyruvate dehydrogenase
. However, only insulin stimulated glycogen synthase activity, indicating that the regulation of synthase may be achieved by intracellular events distinct from those regulating changes in phospholipid metabolism, sugar transport and mitochondrial enzyme activities. It is postulated that exposure to phospholipase C forms diacylglycerol, which is phosphorylated to yield phosphatidate. The increased labelling of CMP-phosphatidate and phosphatidylinositol results from the conversion of phosphatidate into these lipids. The correlation between the effects of phospholipase C on phosphatidate synthesis and changes in adipose-tissue metabolism suggests the possibility that increased phosphatidate may directly or indirectly produce changes in membrane transport and enzyme activities. The pattern of phospholipid labelling produced by insulin, adenosine and oxytocin suggests that these stimuli may also increase phosphatidate synthesis, and, if so, changes in phospholipid metabolism could account for some of the metabolic actions of these stimuli.
...
PMID:Phosphatidic acid and phosphatidylinositol labelling in adipose tissue. Relationship to the metabolic effects of insulin and insulin-like agents. 641 Oct 68